Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Increased m6A modification of lncRNA DBH-AS1 suppresses pancreatic cancer growth and gemcitabine resistance via the miR-3163/USP44 axis
Xin Ye, Liping Wang, Cong Han, et al.
Annals of Translational Medicine (2022) Vol. 10, Iss. 6, pp. 304-304
Open Access | Times Cited: 23

Showing 23 citing articles:

The role of m6A methylation in therapy resistance in cancer
Hengzhao Zhuang, Bo Yu, Dan Tao, et al.
Molecular Cancer (2023) Vol. 22, Iss. 1
Open Access | Times Cited: 76
RNA modifications in cellular metabolism: implications for metabolism-targeted therapy and immunotherapy
Weiwei Liu, Si-Qing Zheng, Li Tian, et al.
Signal Transduction and Targeted Therapy (2024) Vol. 9, Iss. 1
Open Access | Times Cited: 27
Long non-coding RNAs (lncRNAs) signaling in cancer chemoresistance: From prediction to druggability
Giasemi C. Eptaminitaki, Dimitris Stellas, Benjamin Bonavida, et al.
Drug Resistance Updates (2022) Vol. 65, pp. 100866-100866
Closed Access | Times Cited: 49
Roles and implications of mRNA N6‐methyladenosine in cancer
Lingxing Zeng, Xudong Huang, Jialiang Zhang, et al.
Cancer Communications (2023) Vol. 43, Iss. 7, pp. 729-748
Open Access | Times Cited: 20
Emerging roles of m6A RNA modification in cancer therapeutic resistance
Weiwei Liu, Zhongyuan Zhang, Fei Wang, et al.
Experimental Hematology and Oncology (2023) Vol. 12, Iss. 1
Open Access | Times Cited: 17
New insights into the interaction between m6A modification and lncRNA in cancer drug resistance
Yizhou Jin, Zhipeng Fan
Cell Proliferation (2023) Vol. 57, Iss. 4
Open Access | Times Cited: 15
Emerging role of RNA modification and long noncoding RNA interaction in cancer
Liqiong Yang, Lu Tang, Qi Min, et al.
Cancer Gene Therapy (2024) Vol. 31, Iss. 6, pp. 816-830
Open Access | Times Cited: 6
Long non-coding RNAs: Emerging regulators of invasion and metastasis in pancreatic cancer
Mengmeng Shi, Rui Zhang, Hui Lyu, et al.
Journal of Advanced Research (2025)
Open Access
Acquired and intrinsic gemcitabine resistance in pancreatic cancer therapy: Environmental factors, molecular profile and drug/nanotherapeutic approaches
Milad Ashrafizadeh, Kuo Luo, Wei Zhang, et al.
Environmental Research (2023) Vol. 240, pp. 117443-117443
Closed Access | Times Cited: 14
Methyltransferase-like 3 modifications of RNAs: Implications for the pathology in the endocrine system
Xiaojuan Su, Yi Qu, Dezhi Mu
Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease (2024) Vol. 1870, Iss. 3, pp. 167010-167010
Closed Access | Times Cited: 4
The role of N6-methyladenosine-modified non-coding RNAs in the pathological process of human cancer
Lin Luo, Yingwei Zhen, Dazhao Peng, et al.
Cell Death Discovery (2022) Vol. 8, Iss. 1
Open Access | Times Cited: 15
YTHDC2-mediated m6A mRNA modification of Id3 suppresses cisplatin resistance in non-small cell lung cancer
Xifan Wang, Yu’an Hu, Xiaoqing Li, et al.
Journal of Thoracic Disease (2023) Vol. 15, Iss. 3, pp. 1247-1257
Open Access | Times Cited: 8
Role of the long non-coding RNAs in regulation of Gemcitabine response in tumor cells
Amirhosein Maharati, Yalda Samsami, Hanieh Latifi, et al.
Cancer Cell International (2023) Vol. 23, Iss. 1
Open Access | Times Cited: 7
Noncoding RNAs: an emerging modulator of drug resistance in pancreatic cancer
Ling Wei, Jujie Sun, Xingwu Wang, et al.
Frontiers in Cell and Developmental Biology (2023) Vol. 11
Open Access | Times Cited: 5
LncRNA STARD7-AS1 suppresses cervical cancer cell proliferation while promoting autophagy by regulating miR-31-5p/TXNIP axis to inactivate the mTOR signaling
Xiyao Yin, X. R. Liu, Hui Gong, et al.
Journal of Gynecologic Oncology (2024) Vol. 35, Iss. 4
Open Access | Times Cited: 1
Long non-coding RNA MIR4435-2HG promotes pancreatic cancer progression by regulating ABHD17C through sponging miR-128-3p
Zhou Chen, Yan Du, Huaqing Shi, et al.
Translational Cancer Research (2024) Vol. 13, Iss. 8, pp. 4113-4130
Open Access | Times Cited: 1
Role of RNA methylation in the regulation of pancreatic cancer stem cells (Review)
Yoshiko Tsuji, Tomoaki Hara, Sikun Meng, et al.
Oncology Letters (2023) Vol. 26, Iss. 2
Open Access | Times Cited: 4
Regulation of temozolomide resistance via lncRNAs: Clinical and biological properties of lncRNAs in gliomas (Review)
Li Sui, Xiaofang Xie, Peng Fu, et al.
International Journal of Oncology (2022) Vol. 61, Iss. 3
Open Access | Times Cited: 6
Emerging role of interaction between m6A and main ncRNAs in gastrointestinal (GI) cancers
Yating Xu, Xiao Yu, Wenzhi Guo, et al.
Frontiers in Immunology (2023) Vol. 14
Open Access | Times Cited: 2
A novel prognostic model based on telomere-related lncRNAs in gastric cancer
Xuetong Ding, Yi Zhang, Shi-jie You
Translational Cancer Research (2024) Vol. 13, Iss. 9, pp. 4608-4624
Open Access
The Expanding Roles of Long Non‐Coding RNAs in Pancreatic Cancer
Yu Yan, Danzhu Wu, Liyuan Yang, et al.
Advanced Therapeutics (2023) Vol. 6, Iss. 12
Open Access | Times Cited: 1
Construction of a model for predicting the prognosis of liver cancer patients based on CuProtosis-related LncRNA
Yiyang Chen, Wanbang Zhou, Yiju Gong, et al.
Iberoamerican Journal of Medicine (2022) Vol. 5, Iss. 1, pp. 4-16
Open Access | Times Cited: 2
Long non-coding RNAs and tyrosine kinase-mediated drug resistance in pancreatic cancer
Dangran Li, S.-Y. Weng, Kai Zeng, et al.
Gene (2023) Vol. 895, pp. 148007-148007
Closed Access
Page 1

Scroll to top